Federal Agency · Health Resources and Services Administration
Hereditary Hemorrhagic Telangiectasia (HHT) Center
Posted June 8, 2026
Funding
$0 – $2.9M
Closes
July 10, 2026
NAICS
621498
The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) Center Program is to reduce illness and death related to HHT by partnering with clinical center to expand access and coordination of care; creating innovative strategies that support clinicians with identifying and diagnosing HHT cases; and developing a de-identified, aggregate patient data registry to better understand this rare disease and its treatment outcomes.
Award details
Award range: $0 – $2.9M. Applications close on July 10, 2026 (28 days remaining).
Categories
Not categorized
Sign up at GrantRegister to see if this grant matches your organization.
Match my organization →View application on Grants.gov →·Source: Grants.gov·Last seen Jun 12, 2026